PRLB - Protolabs Reports Financial Results for the First Quarter of 2022
Revenue of $124.2 million in the First Quarter of 2022;
GAAP Earnings Per Share of $0.19, Non-GAAP Earnings Per Share of $0.38
Proto Labs, Inc. (“Protolabs” or the “Company”) (NYSE: PRLB), the world’s leading provider of digital manufacturing services, today announced financial results for the first quarter ended March 31, 2022.
First Quarter 2022 Highlights include :
- Revenue for the first quarter of 2022 was $124.2 million, representing a 6.9 percent increase compared to revenue of $116.1 million in the first quarter of 2021.
- Hubs generated $10.3 million of revenue in the first quarter, representing year-over-year growth of 78.6 percent, or approximately 38.2 percent organically. Hubs was acquired on January 22, 2021.
- Net income was $5.1 million, or $0.19 per diluted share.
- Non-GAAP net income was $10.4 million, or $0.38 per diluted share. See “Non-GAAP Financial Measures” below.
“Protolabs finished the first quarter strong after a slow start in January, and we also made progress on our 2022 strategic priorities,” said Rob Bodor, President and Chief Executive Officer. “As an ever-increasing group of companies adopt Manufacturing 4.0, Protolabs will continue to lead the way through focused execution of our strategy.”
Additional First Quarter 2022 Highlights include :
- Protolabs served 23,492 unique product developers during the first quarter of 2022.
- Gross margin was 44.9 percent of revenue; Non-GAAP gross margin was 45.7 percent of revenue. See “Non-GAAP Financial Measures” below.
- EBITDA was $17.8 million, or 14.3 percent of revenue; Adjusted EBITDA was $22.3 million, or 17.9 percent of revenue. See “Non-GAAP Financial Measures” below.
- Cash and investments balance was $105.3 million as of March 31, 2022.
“We are pleased to report first quarter margins ahead of our expectations,” said Dan Schumacher, Interim Chief Financial Officer. “We remain confident in our long-term strategy and are focused on execution. Protolabs will continue to reinforce our sustainable, long-term competitive advantage through profitable growth.”
Non-GAAP Financial Measures
The Company has included non-GAAP revenue growth that excludes the impact of changes in foreign currency exchange rates and revenue earned from its acquisition of Hubs (collectively, “non-GAAP revenue growth”). Management believes these metrics are useful in evaluating the underlying business trends and ongoing operating performance of the Company.
The Company has included earnings before interest, taxes, depreciation and amortization (“EBITDA”) and EBITDA, adjusted for stock-based compensation expense, unrealized loss on foreign currency, and transaction costs (collectively, “Adjusted EBITDA”), in this press release to provide investors with additional information regarding the Company’s financial results. The Company has also included earnings before interest, taxes, depreciation and amortization margin (“EBITDA margin”) and EBITDA margin, adjusted for stock-based compensation expense, unrealized loss on foreign currency, and transaction costs (collectively, “Adjusted EBITDA margin”), in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has included non-GAAP operating margin, adjusted for stock-based compensation expense, amortization expense, and transaction costs (collectively, “non-GAAP operating margin”), in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has included non-GAAP gross margin, adjusted for stock-based compensation expense and amortization expense, (collectively, “non-GAAP gross margin”), in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has included non-GAAP net income, adjusted for stock-based compensation expense, amortization expense, unrealized loss on foreign currency, and transaction costs (collectively, “non-GAAP net income”), in this press release to provide investors with additional information regarding the Company’s financial results.
The Company has provided below reconciliations of GAAP to non-GAAP net income, non-GAAP net income per share, non-GAAP operating margin, non-GAAP income from operations, non-GAAP revenue growth, non-GAAP gross profit, non-GAAP gross margin, EBITDA, Adjusted EBITDA, EBITDA margin, and Adjusted EBITDA margin, the most directly comparable measures calculated and presented in accordance with GAAP. These non-GAAP measures are used by the Company’s management and board of directors to understand and evaluate operating performance and trends and provide useful measures for period-to-period comparisons of the Company’s business. Accordingly, the Company believes that these non-GAAP measures provide useful information to investors and others in understanding and evaluating operating results in the same manner as management and the board of directors.
Conference Call
The Company has scheduled a conference call to discuss its first quarter 2022 financial results and second quarter 2022 outlook today, May 6, 2022, at 8:30 a.m. EDT. To access the call in the U.S. please dial 877-709-8150 or outside the U.S. dial 201-689-8354 at least five minutes prior to the 8:30 a.m. EDT start time. No participant code is required. A simultaneous webcast of the call and accompanying presentation will be available via the investor relations section of the Protolabs website and the following link: https://edge.media-server.com/mmc/p/n7feufxj . A replay will be available for 14 days following the call on the investor relations section of the Protolabs website.
About Protolabs
Protolabs is the world’s leading provider of digital manufacturing services. The e-commerce-based company offers injection molding, CNC machining, 3D printing, and sheet metal fabrication to product developers, engineers, and supply chain teams across the globe. Protolabs serves customers using in-house production capabilities that bring unprecedented speed in tandem with Hubs, a Protolabs Company , which serves customers through its network of premium manufacturing partners. Together, they help companies bring new ideas to market with the fastest and most comprehensive digital manufacturing service in the world. Visit protolabs.com for more information.
Forward-Looking Statements
Statements contained in this press release regarding matters that are not historical or current facts are “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties, and other factors which may cause the results of Protolabs to be materially different than those expressed or implied in such statements. Certain of these risk factors and others are described in the “Risk Factors” section within reports filed with the Securities and Exchange Commission. Other unknown or unpredictable factors also could have material adverse effects on Protolabs’ future results. The forward-looking statements included in this press release are made only as of the date hereof. Protolabs cannot guarantee future results, levels of activity, performance, or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. To the extent permitted under applicable law, Protolabs expressly disclaims any intent or obligation to update any forward-looking statements to reflect subsequent events or circumstances.
| Proto Labs, Inc. |
| Condensed Consolidated Balance Sheets |
| (In thousands) |
| March 31, |
|
|
| December 31, |
| 2022 |
|
|
| 2021 |
| (Unaudited) |
| Assets |
| Current assets |
| Cash and cash equivalents |
| $ |
| 57,239 |
| $ |
| 65,929 |
| Short-term marketable securities |
|
|
| 19,914 |
|
|
| 11,580 |
| Accounts receivable, net |
|
|
| 85,960 |
|
|
| 80,051 |
| Inventory |
|
|
| 14,227 |
|
|
| 13,161 |
| Income taxes receivable |
|
|
| 687 |
|
|
| 1,321 |
| Prepaid expenses and other current assets |
|
|
| 10,185 |
|
|
| 11,450 |
| Total current assets |
|
|
| 188,212 |
|
|
| 183,492 |
| Property and equipment, net |
|
|
| 270,946 |
|
|
| 280,346 |
| Goodwill |
|
|
| 398,319 |
|
|
| 400,610 |
| Other intangible assets, net |
|
|
| 36,234 |
|
|
| 37,998 |
| Long-term marketable securities |
|
|
| 28,196 |
|
|
| 14,340 |
| Operating lease assets |
|
|
| 4,800 |
|
|
| 5,578 |
| Finance lease assets |
|
|
| 1,773 |
|
|
| 1,898 |
| Long-term assets held for sale |
|
|
| 1,985 |
|
|
| - |
| Other long-term assets |
|
|
| 4,286 |
|
|
| 4,320 |
| Total assets |
| $ |
| 934,751 |
| $ |
| 928,582 |
| Liabilities and shareholders' equity |
| Current liabilities |
| Accounts payable |
| $ |
| 17,511 |
| $ |
| 25,364 |
| Accrued compensation |
|
|
| 13,094 |
|
|
| 13,704 |
| Accrued liabilities and other |
|
|
| 23,030 |
|
|
| 11,980 |
| Current operating lease liabilities |
|
|
| 2,253 |
|
|
| 3,298 |
| Current finance lease liabilities |
|
|
| 493 |
|
|
| 550 |
| Income taxes payable |
|
|
| 3,870 |
|
|
| - |
| Total current liabilities |
|
|
| 60,251 |
|
|
| 54,896 |
| Long-term operating lease liabilities |
|
|
| 2,514 |
|
|
| 2,245 |
| Long-term finance lease liabilities |
|
|
| 1,269 |
|
|
| 1,351 |
| Long-term deferred tax liabilities |
|
|
| 32,661 |
|
|
| 35,892 |
| Other long-term liabilities |
|
|
| 6,021 |
|
|
| 5,705 |
| Shareholders' equity |
|
|
| 832,035 |
|
|
| 828,493 |
| Total liabilities and shareholders' equity |
| $ |
| 934,751 |
| $ |
| 928,582 |
| Proto Labs, Inc. |
| Condensed Consolidated Statements of Operations |
| (In thousands, except share and per share amounts) |
| (Unaudited) |
| Three Months Ended |
| March 31, |
| 2022 |
| 2021 |
| Revenue |
| Injection Molding |
| $ |
| 53,398 |
|
|
| $ |
| 56,359 |
|
|
| CNC Machining |
|
|
| 46,098 |
|
|
|
|
| 36,703 |
|
|
| 3D Printing |
|
|
| 19,672 |
|
|
|
|
| 17,235 |
|
|
| Sheet Metal |
|
|
| 4,687 |
|
|
|
|
| 5,219 |
|
|
| Other |
|
|
| 313 |
|
|
|
|
| 610 |
|
|
| Total revenue |
|
|
| 124,168 |
|
|
|
|
| 116,126 |
|
|
| Cost of revenue |
|
|
| 68,364 |
|
|
|
|
| 60,796 |
|
|
| Gross profit |
|
|
| 55,804 |
|
|
|
|
| 55,330 |
|
|
| Operating expenses |
| Marketing and sales |
|
|
| 20,586 |
|
|
|
|
| 19,480 |
|
|
| Research and development |
|
|
| 10,557 |
|
|
|
|
| 12,181 |
|
|
| General and administrative |
|
|
| 16,771 |
|
|
|
|
| 19,408 |
|
|
| Total operating expenses |
|
|
| 47,914 |
|
|
|
|
| 51,069 |
|
|
| Income from operations |
|
|
| 7,890 |
|
|
|
|
| 4,261 |
|
|
| Other loss, net |
|
|
| (300 |
| ) |
|
|
| (313 |
| ) |
| Income before income taxes |
|
|
| 7,590 |
|
|
|
|
| 3,948 |
|
|
| Provision for income taxes |
|
|
| 2,495 |
|
|
|
|
| 236 |
|
|
| Net income |
| $ |
| 5,095 |
|
|
| $ |
| 3,712 |
|
|
| Net income per share: |
| Basic |
| $ |
| 0.19 |
|
|
| $ |
| 0.14 |
|
|
| Diluted |
| $ |
| 0.19 |
|
|
| $ |
| 0.13 |
|
|
| Shares used to compute net income per share: |
| Basic |
|
|
| 27,502,941 |
|
|
|
|
| 27,464,136 |
|
|
| Diluted |
|
|
| 27,510,477 |
|
|
|
|
| 27,698,195 |
|
|
| Proto Labs, Inc. |
| Condensed Consolidated Statements of Cash Flows |
| (In thousands) |
| (Unaudited) |
| Three Months Ended |
| March 31, |
| 2022 |
| 2021 |
| Operating activities |
| Net income |
| $ |
| 5,095 |
|
|
| $ |
| 3,712 |
|
|
| Adjustments to reconcile net income to net cash provided by operating activities: |
| Depreciation and amortization |
|
|
| 10,232 |
|
|
|
|
| 10,059 |
|
|
| Stock-based compensation expense |
|
|
| 4,397 |
|
|
|
|
| 5,620 |
|
|
| Deferred taxes |
|
|
| (3,213 |
| ) |
|
|
| (69 |
| ) |
| Other |
|
|
| 79 |
|
|
|
|
| 126 |
|
|
| Changes in operating assets and liabilities |
|
|
| 1,193 |
|
|
|
|
| (13,023 |
| ) |
| Net cash provided by operating activities |
|
|
| 17,783 |
|
|
|
|
| 6,425 |
|
|
| Investing activities |
| Purchases of property, equipment and other capital assets |
|
|
| (3,069 |
| ) |
|
|
| (6,546 |
| ) |
| Cash used for acquisitions, net of cash acquired |
|
|
| - |
|
|
|
|
| (127,709 |
| ) |
| Purchases of marketable securities |
|
|
| (29,366 |
| ) |
|
|
| (8,227 |
| ) |
| Proceeds from sales of marketable securities |
|
|
| - |
|
|
|
|
| 45,194 |
|
|
| Proceeds from call redemptions and maturities of marketable securities |
|
|
| 6,600 |
|
|
|
|
| 7,155 |
|
|
| Net cash used in investing activities |
|
|
| (25,835 |
| ) |
|
|
| (90,133 |
| ) |
| Financing activities |
| Proceeds from exercises of stock options and other |
|
|
| 6 |
|
|
|
|
| 1,704 |
|
|
| Purchases of shares withheld for tax obligations |
|
|
| (468 |
| ) |
|
|
| (1,994 |
| ) |
| Principal repayments of finance lease obligations |
|
|
| (139 |
| ) |
|
|
| (137 |
| ) |
| Net cash used in financing activities |
|
|
| (601 |
| ) |
|
|
| (427 |
| ) |
| Effect of exchange rate changes on cash and cash equivalents |
|
|
| (37 |
| ) |
|
|
| 306 |
|
|
| Net decrease in cash and cash equivalents |
|
|
| (8,690 |
| ) |
|
|
| (83,829 |
| ) |
| Cash and cash equivalents, beginning of period |
|
|
| 65,929 |
|
|
|
|
| 127,603 |
|
|
| Cash and cash equivalents, end of period |
| $ |
| 57,239 |
|
|
| $ |
| 43,774 |
|
|
| Proto Labs, Inc. |
| Reconciliation of GAAP to Non-GAAP Net Income per Share |
| (In thousands, except share and per share amounts) |
| (Unaudited) |
| Three Months Ended |
| March 31, |
| 2022 |
| 2021 |
| Non-GAAP net income, adjusted for stock-based compensation expense, |
| amortization expense, unrealized loss on foreign currency and |
| transaction costs |
| GAAP net income |
| $ |
| 5,095 |
|
|
| $ |
| 3,712 |
|
|
| Add back: |
| Stock-based compensation expense |
|
|
| 4,397 |
|
|
|
|
| 5,620 |
|
|
| Amortization expense |
|
|
| 1,545 |
|
|
|
|
| 1,543 |
|
|
| Unrealized loss on foreign currency |
|
|
| 89 |
|
|
|
|
| 622 |
|
|
| Transaction costs 1 |
|
|
| - |
|
|
|
|
| 2,515 |
|
|
| Total adjustments 2 |
|
|
| 6,031 |
|
|
|
|
| 10,300 |
|
|
| Income tax benefits on adjustments 3 |
|
|
| (682 |
| ) |
|
|
| (3,001 |
| ) |
| Non-GAAP net income |
| $ |
| 10,444 |
|
|
| $ |
| 11,011 |
|
|
| Non-GAAP net income per share: |
| Basic |
| $ |
| 0.38 |
|
|
| $ |
| 0.40 |
|
|
| Diluted |
| $ |
| 0.38 |
|
|
| $ |
| 0.40 |
|
|
| Shares used to compute non-GAAP net income per share: |
| Basic |
|
|
| 27,502,941 |
|
|
|
|
| 27,464,136 |
|
|
| Diluted |
|
|
| 27,510,477 |
|
|
|
|
| 27,698,195 |
|
|
| 1 Transaction costs include direct costs incurred in the Company's acquisition of Hubs, Inc. |
| 2 Stock-based compensation expense, amortization expense, unrealized loss on foreign currency and transaction costs were included in the following GAAP consolidated statement of operations categories: |
| Three Months Ended |
| March 31, |
| 2022 |
| 2021 |
| Cost of revenue |
| $ |
| 929 |
|
|
| $ |
| 977 |
|
|
| Marketing and sales |
|
|
| 737 |
|
|
|
|
| 853 |
|
|
| Research and development |
|
|
| 629 |
|
|
|
|
| 624 |
|
|
| General and administrative |
|
|
| 3,647 |
|
|
|
|
| 7,224 |
|
|
| Total operating expenses |
|
|
| 5,013 |
|
|
|
|
| 8,701 |
|
|
| Other (income) expense, net |
|
|
| 89 |
|
|
|
|
| 622 |
|
|
| Total adjustments |
| $ |
| 6,031 |
|
|
| $ |
| 10,300 |
|
|
| 3 For the three-month periods ended March 31, 2022 and 2021, income tax effects were calculated using the effective tax rate for the relevant jurisdictions. The Company's non-GAAP tax rates differ from its GAAP tax rates due primarily to the mix of activity incurred in domestic and foreign tax jurisdictions and removing effective tax rate benefits from stock-based compensation activity in the quarter. |
| Proto Labs, Inc. |
| Reconciliation of GAAP to Non-GAAP Gross Margin |
| (In thousands) |
| (Unaudited) |
| Three Months Ended |
| March 31, |
| 2022 |
| 2021 |
| Revenue |
| $ |
| 124,168 |
|
|
| $ |
| 116,126 |
|
|
| Gross Profit |
|
|
| 55,804 |
|
|
|
|
| 55,330 |
|
|
| GAAP gross margin |
|
|
| 44.9 |
| % |
|
|
| 47.6 |
| % |
| Add back: |
| Stock-based compensation expense |
|
|
| 587 |
|
|
|
|
| 635 |
|
|
| Amortization expense |
|
|
| 342 |
|
|
|
|
| 342 |
|
|
| Total adjustments |
|
|
| 929 |
|
|
|
|
| 977 |
|
|
| Non-GAAP gross profit |
| $ |
| 56,733 |
|
|
| $ |
| 56,307 |
|
|
| Non-GAAP gross margin |
|
|
| 45.7 |
| % |
|
|
| 48.5 |
| % |
| Proto Labs, Inc. |
| Reconciliation of GAAP to Non-GAAP Operating Margin |
| (In thousands) |
| (Unaudited) |
| Three Months Ended |
| March 31, |
| 2022 |
| 2021 |
| Revenue |
| $ |
| 124,168 |
|
|
| $ |
| 116,126 |
|
|
| Income from operations |
|
|
| 7,890 |
|
|
|
|
| 4,261 |
|
|
| GAAP operating margin |
|
|
| 6.4 |
| % |
|
|
| 3.7 |
| % |
| Add back: |
| Stock-based compensation expense |
|
|
| 4,397 |
|
|
|
|
| 5,620 |
|
|
| Amortization expense |
|
|
| 1,545 |
|
|
|
|
| 1,543 |
|
|
| Transaction costs 1 |
|
|
| - |
|
|
|
|
| 2,515 |
|
|
| Total adjustments |
|
|
| 5,942 |
|
|
|
|
| 9,678 |
|
|
| Non-GAAP income from operations |
| $ |
| 13,832 |
|
|
| $ |
| 13,939 |
|
|
| Non-GAAP operating margin |
|
|
| 11.1 |
| % |
|
|
| 12.0 |
| % |
| 1 Transaction costs include direct costs incurred in the Company's acquisition of Hubs, Inc. |
| Proto Labs, Inc. |
| Reconciliation of GAAP Net Income to EBITDA and Adjusted EBITDA |
| (In thousands) |
| (Unaudited) |
| Three Months Ended |
| March 31, |
| 2022 |
| 2021 |
| Revenue |
| $ |
| 124,168 |
|
|
| $ |
| 116,126 |
|
|
| GAAP net income |
|
|
| 5,095 |
|
|
|
|
| 3,712 |
|
|
| GAAP net income margin |
|
|
| 4.1 |
| % |
|
|
| 3.2 |
| % |
| GAAP net income |
| $ |
| 5,095 |
|
|
| $ |
| 3,712 |
|
|
| Amortization expense |
|
|
| 1,545 |
|
|
|
|
| 1,543 |
|
|
| Depreciation expense |
|
|
| 8,687 |
|
|
|
|
| 8,516 |
|
|
| Interest income, net |
|
|
| (45 |
| ) |
|
|
| (87 |
| ) |
| Tax expense |
|
|
| 2,495 |
|
|
|
|
| 236 |
|
|
| EBITDA |
|
|
| 17,777 |
|
|
|
|
| 13,920 |
|
|
| EBITDA Margin |
|
|
| 14.3 |
| % |
|
|
| 12.0 |
| % |
| Add back: |
| Stock-based compensation expense |
|
|
| 4,397 |
|
|
|
|
| 5,620 |
|
|
| Unrealized loss on foreign currency |
|
|
| 89 |
|
|
|
|
| 622 |
|
|
| Transaction costs 1 |
|
|
| - |
|
|
|
|
| 2,515 |
|
|
| Total adjustments |
|
|
| 4,486 |
|
|
|
|
| 8,757 |
|
|
| Adjusted EBITDA |
| $ |
| 22,263 |
|
|
| $ |
| 22,677 |
|
|
| Adjusted EBITDA Margin |
|
|
| 17.9 |
| % |
|
|
| 19.5 |
| % |
| 1 Transaction costs include direct costs incurred in the Company's acquisition of Hubs, Inc. |
| Proto Labs, Inc. |
| Comparison of GAAP to Non-GAAP Revenue Growth |
| (In thousands) |
| (Unaudited) |
| Three Months Ended March 31, 2022 |
| Three Months Ended March 31, 2021 |
| % |
| GAAP |
| Foreign Currency 1 |
| Hubs Acquisition 2 |
| Non-GAAP |
| GAAP |
| Change 3 |
| % Change Organic 4 |
| Revenues |
| United States |
| $ |
| 95,496 |
| $ |
| - |
| $ |
| (1,049 |
| ) |
| $ |
| 94,447 |
| $ |
| 91,053 |
| 4.9 |
| % |
| 3.7 |
| % |
| Europe |
|
|
| 24,586 |
|
|
| 1,151 |
|
|
| (1,279 |
| ) |
|
|
| 24,458 |
|
|
| 21,449 |
| 14.6 |
| 14.0 |
| Japan |
|
|
| 4,086 |
|
|
| 392 |
|
|
| - |
|
|
|
|
| 4,478 |
|
|
| 3,624 |
| 12.7 |
| 23.6 |
| Total Revenue |
| $ |
| 124,168 |
| $ |
| 1,543 |
| $ |
| (2,328 |
| ) |
| $ |
| 123,383 |
| $ |
| 116,126 |
| 6.9 |
| % |
| 6.2 |
| % |
| 1 Revenue for the three-month period ended March 31, 2022 has been recalculated using 2021 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates. |
|
|
|
|
| 2 Revenue for the three-month period ended March 31, 2022 has been recalculated to exclude revenue earned from the Company's acquisition of Hubs, Inc. for the period from January 1, 2022 to January 21, 2022 to provide information useful in evaluating the underlying business trends excluding the impact of acquisitions. The Hubs, Inc. acquisition occurred on January 22, 2021 and was included in 2021 revenue after that date. |
|
|
| 3 This column presents the percentage change from GAAP revenue for the three-month period ended March 31, 2021 to GAAP revenue for the three-month period ended March 31, 2022. |
|
|
| 4 This column presents the percentage change from GAAP revenue for the three-month period ended March 31, 2021 to non-GAAP revenue for the three-month period ended March 31, 2022 (as recalculated using the foreign currency exchange rates in effect during the three-month period ended March 31, 2021, excluding the impact of Hubs, Inc. acquisition) in order to provide a constant-currency comparison. |
| Proto Labs, Inc. |
| Product Developer Information |
| (Unaudited) |
| Three Months Ended |
| March 31, |
| 2022 |
|
|
| 2021 |
| Unique product developers and engineers served |
| 23,492 |
| 22,605 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220506005042/en/
Investor Relations Contact
Protolabs
Ryan Johnsrud, 612-225-4873
Manager – Investor Relations and FP&A
ryan.johnsrud@protolabs.com
Media Contact
Protolabs
Brent Renneke, 763-479-7704
PR & Media Strategist
brent.renneke@protolabs.com